Physical activity, exercise benefit patients with lung cancer, survivors
the ONA take:
According to a new study published in the Journal of Thoracic Oncology, researchers at The Medical University of South Carolina in Charleston, South Carolina, have found that physical activity should be considered as a therapeutic option of patients with lung cancer as exercise and physical activity have been shown to reduce symptoms, improve quality of life, increase exercise tolerance, and decrease length of hospitalization and post-surgery complications for lung cancer.
The authors found that most patients with lung cancer want advice about physical activity from a cancer center physician before cancer therapy and exercise guidance may improve compliance with the use of a dedicated program. Another important finding was that exercise and physical activity are safe for those with lung cancer.
In addition, both patients with lung cancer and lung cancer survivors experienced the same benefits of increased activity, particularly improved symptoms and quality of life.
The authors conclude that health care professionals should consider physical activity early and encourage physical activity in patients any stage of lung cancer and lung cancer survivors.
Physical activity have been shown to reduce lung cancer symptoms, improve quality of life.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- PPIs Negatively Impact Outcomes of Patients Treated With Capecitabine
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Atypical Teratoid/rhabdoid Tumors: Challenges and Search for Solutions
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Pseudohyperkalemia: False Potassium Levels Occur in a Patient With Lymphoma
- Atezolizumab Granted FDA Approval for Specific Cases of NSCLC
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|